GLP-1 RA Use and Major Adverse Cardiovascular Events in Patients With Monoclonal Gammopathy of Undetermined Significance
The findings of this cohort study of GLP-1 RA use vs no use in patients with MGUS and diabetes suggest the potential of GLP-1 RA for primary prevention of MACCE. These findings warrant further investigation in prospective randomized trials.
Authors
- Anushri Soni
- Alokkumar Jha (ORCID: https://orcid.org/0000-0002-8024-5854)
- Lauren A. Baldassarre (ORCID: https://orcid.org/0000-0003-4173-3449)
- Michael G. Nanna (ORCID: https://orcid.org/0000-0002-5487-4542)
- Zafer Akman (ORCID: https://orcid.org/0000-0002-6317-4417)
- Antony Gonzales-Uribe
- Pei‐Lun Lee
- A.M.E. Nouri (ORCID: https://orcid.org/0000-0001-6005-1414)
- Jennifer M. Kwan (ORCID: https://orcid.org/0000-0002-4715-1848)
- Ahmed Ashraf Morgan
- S.R. Desphande
- Yu‐Ling Chang (ORCID: https://orcid.org/0000-0003-2851-3652)
- Dimitrios Varrias (ORCID: https://orcid.org/0000-0001-9778-1728)
- Raiza Rossi (ORCID: https://orcid.org/0000-0001-6898-2192)
- Sarah C. Hull (ORCID: https://orcid.org/0000-0001-9125-410X)
- Yu-Shiuan Lin (ORCID: https://orcid.org/0000-0002-3049-4166)
- Eli Muchtar (ORCID: https://orcid.org/0000-0003-2210-2174)
- Golsa Babapour (ORCID: https://orcid.org/0009-0009-5018-3099)
- Kuan-Yu Chi
- Terri L. Parker
- Junmin Song
- Yasmin Lessa
Institutions
- Mayo Clinic (US)
- Cornell University (US)
- Jacobi Medical Center (US)
- Taipei Medical University Hospital (TW)
- Yale Cancer Center (US)
- Yale University (US)
- National Cheng Kung University Hospital (TW)
- Weill Cornell Medicine (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-06-30
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.17541
- Citations
- 3
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 3.88
Funders
- Yale University